The Society of Nuclear Medicine and Molecular Imaging (SNMMI) addressed two letters to Aetna recommending the health insurance giant alter its radiopharmaceutical coverage policy to include PET imaging agents dotatate and fluciclovine.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) addressed two letters to Aetna recommending the health insurance giant alter its radiopharmaceutical coverage policy to include PET imaging agents dotatate and fluciclovine.